Europe DNA/RNA Sample Extraction and Isolation Market to Grow with a CAGR of 6.62% through 2030

Advancements in automation technologies for sample preparation and the surge in demand for high-throughput sequencing is expected to drive the Europe DNA/RNA Sample Extraction and Isolation Market growth in the forecast period, 2026-2030

 According to TechSci Research report, “Europe DNA/RNA Sample Extraction and Isolation Market By Country, Competition, Forecast and Opportunities, 2030F”, the Europe DNA/RNA Sample Extraction and Isolation Market stood at USD 646.13 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 6.62% through 2030.

The Europe DNA/RNA Sample Extraction and Isolation Market is rising due to rising innovations in genomic research and the growing application of nucleic acid technologies in healthcare. Increasing research activities in molecular biology and biotechnology are driving the demand for advanced extraction and isolation techniques. The development of high-throughput systems tailored for large-scale studies is playing a key role in meeting the needs of academic and industrial research. Furthermore, the growing emphasis on early disease detection and advances in molecular diagnostics are significantly boosting the market.

Emerging technologies, such as microfluidics and lab-on-a-chip systems, are revolutionizing sample preparation processes by providing compact and efficient solutions. Partnerships between academic institutions and industry players are accelerating the commercialization of novel products designed for improved performance and reduced costs. The rising popularity of point-of-care testing is further driving the adoption of portable DNA/RNA extraction devices, addressing the growing demand for decentralized diagnostic solutions. Additionally, the focus on automation and integration of robotic systems in genomic workflows is opening up new opportunities for market expansion.

Challenges persist, such as the need for continuous innovation to address limitations in existing extraction methods, including contamination risks and yield variability. The dependence on sophisticated infrastructure and specialized expertise restricts the accessibility of advanced solutions to resource-limited settings. Additionally, maintaining the balance between innovation and regulatory compliance remains a critical issue for companies in this space. Ensuring that new solutions meet the stringent quality and safety requirements without inflating costs will be essential for overcoming these hurdles and sustaining the market's growth trajectory.       

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Europe DNA/RNA Sample Extraction and Isolation Market”

The Europe DNA/RNA Sample Extraction and Isolation Market is segmented into product type, technology, application, end user, country distribution, and company.

Based on the Application, NGS emerged as the fastest growing segment in the Europe DNA/RNA Sample Extraction and Isolation Market during the forecast period. This is due to its expanding applications in genomics, personalized medicine, and research. NGS technologies enable high-throughput, high-accuracy sequencing of DNA and RNA, providing detailed insights into genetic variations, mutations, and expression patterns. This has made NGS a critical tool in fields such as cancer research, genetic disorder diagnostics, and precision medicine. As the demand for personalized treatments based on genetic profiles increases, NGS has become integral to drug development and clinical diagnostics. The affordability and speed of NGS have improved in recent years, further accelerating its adoption in both clinical and research settings. NGS is increasingly used for whole-genome sequencing, transcriptome analysis, and microbiome studies, driving its adoption across various sectors. Additionally, the rising prevalence of genetic diseases and the growing need for comprehensive molecular profiling have contributed to the rapid growth of NGS in the European market.

Based on Country, United Kingdom emerged as the fastest growing country in the Europe DNA/RNA Sample Extraction and Isolation Market during the forecast period. This is due to its strong focus on genomic research, healthcare innovation, and biotechnology development. The UK is home to leading research institutions and universities, such as the Francis Crick Institute and the University of Cambridge, which drive cutting-edge advancements in genomic research and molecular diagnostics. These institutions actively contribute to the demand for DNA and RNA extraction technologies, particularly in areas like cancer research, genetic disorders, and personalized medicine. The UK's healthcare system also supports the growing demand for molecular diagnostics, with increasing investments in precision medicine and genomic sequencing. Initiatives such as the 100,000 Genomes Project, which aims to sequence the genomes of patients with rare diseases and cancers, have significantly boosted the use of DNA/RNA sample extraction technologies.

Major companies operating in Europe DNA/RNA Sample Extraction and Isolation Market are:

• BASF A/S
• Bio-Rad Laboratories GmbH
• F. Hoffmann-La Roche AG
• ACON Laboratories, Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Minerva Biolabs GmbH
• QIAGEN N.V.
• Abnova Corporation
• Macherey-Nagel GmbH & Co. KG 

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Europe DNA/RNA Sample Extraction and Isolation Market is expanding due to the increasing integration of artificial intelligence (AI) and machine learning (ML) technologies in genomic research and diagnostics. AI and ML are enhancing the efficiency and accuracy of data analysis in genomics, allowing researchers to process large datasets faster and identify genetic variations with greater precision. This technological advancement is leading to more effective DNA/RNA extraction processes, streamlining workflows, and reducing errors in molecular diagnostics. As AI and ML continue to evolve, they are expected to play a crucial role in accelerating personalized medicine, creating a significant demand for high-quality DNA/RNA extraction tools that can support these advanced analytical techniques. This integration of AI-driven solutions into genomics is thus contributing to the growth of the market.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Europe DNA/RNA Sample Extraction and Isolation Market By Product Type (Consumables, Instruments), By Technology (Silica-Based, Magnetic Particle Technology, Automated Spin Column-Based, Magnetic Bead-Based, Automated Liquid Handling, Other Technologies), By Application (PCR, NGS, Cloning, Microarray, Blotting Techniques, Other Applications), By End User (Clinical Diagnostic and Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others), By Country, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated the future growth potential of Europe DNA/RNA Sample Extraction and Isolation Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Europe DNA/RNA Sample Extraction and Isolation Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com